Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $131.66 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ethicon US, LLC | $29.98 | 2 | $0 (2023) |
| Braintree Laboratories, Inc. | $27.18 | 2 | $0 (2023) |
| Smith+Nephew, Inc. | $20.03 | 1 | $0 (2023) |
| PolyNovo North America LLC | $19.62 | 1 | $0 (2023) |
| TELA Bio, Inc. | $18.96 | 1 | $0 (2022) |
| Allergan Inc. | $15.89 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $80.13 | 5 | Braintree Laboratories, Inc. ($27.18) |
| 2022 | $18.96 | 1 | TELA Bio, Inc. ($18.96) |
| 2021 | $16.68 | 1 | Ethicon US, LLC ($16.68) |
| 2018 | $15.89 | 1 | Allergan Inc. ($15.89) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/26/2023 | Smith+Nephew, Inc. | PICO 7 (Device), RENASYS GO v2 HOME | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Negative Pressure Wound Therapy | ||||||
| 07/20/2023 | PolyNovo North America LLC | — | Food and Beverage | Cash or cash equivalent | $19.62 | General |
| 06/22/2023 | Ethicon US, LLC | Enseal (Device) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Energy | ||||||
| 03/02/2023 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: GI COLON PREP | ||||||
| 01/05/2023 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: GI COLON PREP | ||||||
| 06/02/2022 | TELA Bio, Inc. | OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) (Device) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Surgical Mesh | ||||||
| 05/04/2021 | Ethicon US, LLC | SURGICEL NU-KNIT (Device) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Biosurgical | ||||||
| 02/21/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 269 | 293 | $119,318 | $24,148 |
| 2022 | 8 | 298 | 328 | $128,639 | $24,416 |
| 2021 | 11 | 310 | 347 | $117,208 | $26,034 |
| 2020 | 9 | 278 | 308 | $86,832 | $21,013 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 37 | 37 | $43,182 | $7,288 | 16.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 65 | 82 | $6,806 | $3,273 | 48.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 40 | 40 | $8,240 | $2,816 | 34.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $6,615 | $2,303 | 34.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 30 | 30 | $19,710 | $2,140 | 10.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 12 | 12 | $9,936 | $2,053 | 20.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $16,813 | $1,641 | 9.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 22 | $3,058 | $1,029 | 33.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 13 | $2,678 | $966.70 | 36.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 19 | $2,280 | $638.69 | 28.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 46 | 46 | $54,004 | $8,597 | 15.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 86 | 112 | $9,304 | $4,177 | 44.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 53 | 53 | $10,816 | $3,202 | 29.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 25 | 25 | $7,848 | $2,696 | 34.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 30 | 31 | $20,367 | $2,114 | 10.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 26 | 28 | $3,896 | $1,518 | 39.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 20 | 20 | $19,780 | $1,197 | 6.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 13 | $2,624 | $913.65 | 34.8% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 34 | 35 | $40,787 | $6,471 | 15.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 58 | 58 | $10,962 | $3,920 | 35.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 74 | 95 | $7,284 | $3,603 | 49.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 23 | 23 | $6,624 | $2,428 | 36.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 13 | 13 | $10,361 | $2,312 | 22.3% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 21 | 21 | $13,469 | $1,702 | 12.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 31 | 31 | $4,007 | $1,685 | 42.1% |
About Dr. Nathan Epp, DO
Dr. Nathan Epp, DO is a Surgery healthcare provider based in Peru, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346325719.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nathan Epp, DO has received a total of $131.66 in payments from pharmaceutical and medical device companies, with $80.13 received in 2023. These payments were reported across 8 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($131.66).
As a Medicare-enrolled provider, Epp has provided services to 1,155 Medicare beneficiaries, totaling 1,276 services with total Medicare billing of $95,611. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Surgery
- Location Peru, IN
- Active Since 10/26/2006
- Last Updated 09/14/2020
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1346325719
Products in Payments
- SUTAB (Drug) $27.18
- PICO 7 (Device) $20.03
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) (Device) $18.96
- SURGICEL NU-KNIT (Device) $16.68
- AVYCAZ (Drug) $15.89
- Enseal (Device) $13.30
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.